A
$ Value
$0
Shares
31,750
Price
$0
Filed
Apr 2
Insider
Name
Emany Sravan Kumar
Title
Chief Financial Officer
CIK
0001897662
Roles
Officer
Transaction Details
Transaction Date
2026-03-31
Code
A
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
105,456
Footnotes
Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSUs vest in four substantially equal installments on each of the first four anniversaries of the date of grant, subject to the Reporting Person's continued service with BEAM through each vesting date.
Filing Info
Emany Sravan Kumar's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | BEAM | A | $0 |
| 2025-05-07 | ASRT | A | $0 |
| 2025-05-07 | ASRT | A | $0 |
Other Insiders at BEAM (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Evans John M.
CEO
|
— | $1.9M | 2026-04-01 |
|
Ciaramella Giuseppe
President
|
— | $290K | 2026-04-01 |
|
Bellon Christine
Chief Legal Officer
|
— | $146K | 2026-04-01 |
|
Simon Amy
Chief Medical Officer
|
— | $165K | 2026-04-01 |
|
Cavanagh Bethany J
SVP, Finance and Treasurer
|
— | $80K | 2026-04-01 |